AOD 9604 5 mg Peptide Sciences

Description

AOD 9604 5 mg Peptide Sciences — AOD-9604 from Peptide Sciences at 5 mg. Synthetic fragment (aa 176-191) of HGH retaining the lipolytic action without IGF-1/anabolic pathway activation. Clean fat-loss focused peptide.

Key Benefits

• Fragment of HGH (amino acids 177–191) — lipolytic only
• No growth/IGF-1 effects (unlike full HGH)
• Cutting-phase compound without insulin-resistance risk
• Subcutaneous dosing, typically pre-cardio or fasted
• No HPTA impact, no PCT required
• Each unit dosed at 5 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 300 mcg/day SubQ, fasted pre-cardio for maximum lipolytic window. Cycles 4–12 weeks. Stackable with any AAS protocol.

How It Works

15-amino-acid fragment of the C-terminal region of human growth hormone. Isolates the lipolytic (fat-mobilising) action of HGH without the growth/IGF-1 pathways that drive mass gain and insulin-resistance concerns.

Pharmacokinetics

Plasma half-life approximately 1–2 hours. Daily SubQ dosing. Reconstituted fridge 4–6 weeks.

Potential Side Effects

Very clean profile. No HPTA effect. No insulin-sensitivity impact. Mild injection-site reactions possible.

Cycle & Stacking Guide

4–12 week cutting protocols at 300 mcg/day fasted. Stacks with clenbuterol, T3, or AAS cutting cycles for additive fat-loss. Not a mass-building compound.

Manufacturer Notes

Peptide Sciences is a research-only peptide manufacturer with HPLC-verified purity documentation on every SKU. Vials are lyophilised and ship with a third-party assay report.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.